These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 23603662)
1. Myeloperoxidase induces the priming of platelets. Kolarova H; Klinke A; Kremserova S; Adam M; Pekarova M; Baldus S; Eiserich JP; Kubala L Free Radic Biol Med; 2013 Aug; 61():357-69. PubMed ID: 23603662 [TBL] [Abstract][Full Text] [Related]
2. The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation. Straub A; Wendel HP; Azevedo R; Ziemer G Eur J Cardiothorac Surg; 2005 Apr; 27(4):617-21. PubMed ID: 15784360 [TBL] [Abstract][Full Text] [Related]
3. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. Totani L; Dell'Elba G; Martelli N; Di Santo A; Piccoli A; Amore C; Evangelista V Thromb Haemost; 2012 Jun; 107(6):1130-40. PubMed ID: 22436970 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of platelet functional changes and effects of anti-platelet agents on in vivo hemostasis under different gravity conditions. Li S; Shi Q; Liu G; Zhang W; Wang Z; Wang Y; Dai K J Appl Physiol (1985); 2010 May; 108(5):1241-9. PubMed ID: 20133435 [TBL] [Abstract][Full Text] [Related]
5. Red blood cells serve as intravascular carriers of myeloperoxidase. Adam M; Gajdova S; Kolarova H; Kubala L; Lau D; Geisler A; Ravekes T; Rudolph V; Tsao PS; Blankenberg S; Baldus S; Klinke A J Mol Cell Cardiol; 2014 Sep; 74():353-63. PubMed ID: 24976018 [TBL] [Abstract][Full Text] [Related]
6. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction. Liao CH; Cheng JT; Teng CM Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105 [TBL] [Abstract][Full Text] [Related]
7. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men. Wang JS; Liao CH Thromb Haemost; 2004 Mar; 91(3):587-94. PubMed ID: 14983236 [TBL] [Abstract][Full Text] [Related]
8. Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesis. Rozalski M; Kassassir H; Siewiera K; Klepacka A; Sychowski R; Watala C Thromb Res; 2014 Jun; 133(6):1097-104. PubMed ID: 24731558 [TBL] [Abstract][Full Text] [Related]
9. Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils. Aktan I; Dunkel B; Cunningham FM Vet Immunol Immunopathol; 2013 Apr; 152(3-4):209-17. PubMed ID: 23332730 [TBL] [Abstract][Full Text] [Related]
11. Postprandial cell inflammatory response to a standardised fatty meal in subjects at different degree of cardiovascular risk. Tamburrelli C; Gianfagna F; D'Imperio M; De Curtis A; Rotilio D; Iacoviello L; de Gaetano G; Donati MB; Cerletti C Thromb Haemost; 2012 Mar; 107(3):530-7. PubMed ID: 22274593 [TBL] [Abstract][Full Text] [Related]
13. Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis. Momi S; Caracchini R; Falcinelli E; Evangelista S; Gresele P Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):820-9. PubMed ID: 24558107 [TBL] [Abstract][Full Text] [Related]
14. C1q regulates collagen-dependent production of reactive oxygen species, aggregation and levels of soluble P-selectin in whole blood. Skoglund C; Wetterö J; Bengtsson T Immunol Lett; 2012 Feb; 142(1-2):28-33. PubMed ID: 22142906 [TBL] [Abstract][Full Text] [Related]
15. Sulfatides activate platelets through P-selectin and enhance platelet and platelet-leukocyte aggregation. Merten M; Beythien C; Gutensohn K; Kühnl P; Meinertz T; Thiagarajan P Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):258-63. PubMed ID: 15528476 [TBL] [Abstract][Full Text] [Related]
16. Tangeretin regulates platelet function through inhibition of phosphoinositide 3-kinase and cyclic nucleotide signaling. Vaiyapuri S; Ali MS; Moraes LA; Sage T; Lewis KR; Jones CI; Gibbins JM Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2740-9. PubMed ID: 24135020 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide infusion alleviates cellular activation during preparation, leukofiltration and storage of platelets. Wong K; Li X Transfus Apher Sci; 2004 Feb; 30(1):29-39. PubMed ID: 14746819 [TBL] [Abstract][Full Text] [Related]
18. N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. Kalev-Zylinska ML; Green TN; Morel-Kopp MC; Sun PP; Park YE; Lasham A; During MJ; Ward CM Thromb Res; 2014 May; 133(5):837-47. PubMed ID: 24593912 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. Sheu JR; Fong TH; Liu CM; Shen MY; Chen TL; Chang Y; Lu MS; Hsiao G Br J Pharmacol; 2004 Sep; 143(1):193-201. PubMed ID: 15289295 [TBL] [Abstract][Full Text] [Related]
20. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation. Sim DS; Dilks JR; Flaumenhaft R Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]